MFMagdalena Filuk

Magdalena Filuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magdalena Filuk has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OVERTRAINING SYNDROME AND MENTAL HEALTH IN ATHLETES - A LITERATURE REVIEW

    by Dominika Dutkiewicz, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Julia Czerniewska, Marta Handzel

    Overtraining Syndrome (OTS) is a complex biopsychosocial condition arising from a chronic imbalance between training load and recovery. OTS produces numerous psychiatric symptoms that remain systematically underrecognized in clinical practice. This review examines the neurobiological mechanisms linking OTS to mental health disorders, characterizes its psychiatric symptomatology, clarifies differential diagnosis with primary psychiatric conditions, and synthesizes current evidence on monitoring, prevention, and management. OTS affects numerous elite athletes during their careers, with a relapse rate of 80–90% within three years of recovery. Its neurobiological mechanisms — HPA axis exhaustion, serotonergic receptor dysregulation, neuroinflammatory activation, and autonomic nervous system dysfunction — overlap substantially with those of major depressive disorder, providing a mechanistic basis for the extensive psychiatric comorbidity observed clinically. OTS presents across three dimensions: affective and anxiety symptoms, neurocognitive and somatic impairment, and burnout. Differential diagnosis requires systematic exclusion of primary psychiatric disorders, Relative Energy Deficiency in Sport (RED-S), and organic pathology. Prevention and management form a continuum encompassing psychological monitoring, primary prevention strategies, and — in established OTS — multidisciplinary treatment including psychiatric and psychological interventions. OTS is a biopsychosocial condition whose psychiatric dimension is clinically substantial yet underdiagnosed. Its neurobiological overlap with major depressive disorder warrants integration of psychiatric expertise into the routine evaluation and management of overtrained athletes. The field remains constrained by the absence of validated diagnostic criteria and evidence-based psychological interventions — gaps that sports psychiatry is well-positioned to address.

  • Open Access

    GLP-1 RECEPTOR AGONISTS AND ALCOHOL USE DISORDER: PROMISE FOR A NEW TREATMENT APPROACH

    by Jakub Fidelus, Klaudia Jurkowska, Dominika Dutkiewicz, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Julia Czerniewska, Marta Handzel

    The role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as effective glucose-lowering and nephroprotective agents in type 2 diabetes is well established. Their emergence as treatments for obesity is considerably more recent. In the short time since this indication was approved, these medications have attracted considerable attention, and their use in clinical practise has expanded rapidly. Amid this rapid expansion, clinicians have encountered growing anecdotal reports from patients taking GLP-1RAs describing unexpected improvements in substance use behaviours. Such reports are consistent with a growing body of preclinical evidence demonstrating that GLP-1RAs reduce intake of alcohol and other addictive substances. Whether preclinical observations can be replicated in human studies is currently being tested in clinical trials. One prevailing hypothesis suggests that glucagon-like peptide-1 (GLP-1) exerts its effects via central mechanisms, including, at least in part, modulation of dopamine transmission. Studies imply that activation of central glucagon-like peptide -1 receptors (GLP-1Rs) functionally regulates the mesolimbic reward pathway and reduces addiction-like behaviors in rodent models. This narrative review summarizes the existing evidence regarding the effects of GLP-1RAs on alcohol consumption. Relevant studies published between January 2015 and March 2026 were identified via literature search. Collectively, the evidence supporting GLP-1RAs for the treatment of AUD is promising yet inconsistent, with randomized clinical trials yielding mixed results for the primary outcome of reduced alcohol consumption. Although current findings do not justify changes to clinical practice, they point toward potential benefits of GLP-1RAs, extending beyond glycemic and weight control, particularly among patients with AUD.

  • Open Access

    SEMAGLUTIDE FOR WEIGHT REDUCTION: A COMPARATIVE ANALYSIS WITH OTHER PHARMACOLOGICAL TREATMENTS

    by Marta Handzel, Julia Czerniewska, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Dominika Dutkiewicz

    Obesity is a chronic, complex disease linked to major illness and death. Related conditions include heart disease, type 2 diabetes, and cancer. Its global prevalence has soared, demonstrating the need for treatments beyond lifestyle change. Pharmacotherapy is essential, particularly for people unable to maintain weight loss through behavioural interventions. This review evaluates the efficacy and safety of glucagon-like peptide-1 (GLP-1) receptor agonists, specifically semaglutide and liraglutide. These are assessed against established anti-obesity drugs, including orlistat and phentermine. A structured search was carried out across PubMed, Scopus, and Google Scholar. Priority was given to randomised controlled trials, meta-analyses, and large observational studies published from 2010 to 2025. Key clinical trial programmes, such as STEP, SUSTAIN, LEADER, SELECT, and SURMOUNT, were critically reviewed. Semaglutide shows superior efficacy. Mean weight reductions often exceed 10–15%. These reductions are linked to considerable improvements in glycaemic and cardiometabolic parameters. Liraglutide provides modest weight loss but has proven cardiovascular benefits. Orlistat and phentermine have lower efficacy. They also have tolerability issues and limited long-term use. Despite their strengths, GLP-1 receptor agonists cause gastrointestinal side effects, high cost, and have limited long-term safety data. GLP-1 receptor agonists represent a major advance, making obesity treatment more targeted. Future studies ought to focus on long-term outcomes, accessibility, and improving the tolerability and affordability of therapy.

  • Open Access

    APPLICATION OF ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR DISEASE DIAGNOSTICS: OPPORTUNITIES AND CHALLENGES

    by Marianna Ciastoń, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Magdalena Filuk, Jakub Fidelus, Dominika Dutkiewicz, Julia Czerniewska, Marta Handzel

    Backround: Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide and represent a major burden on healthcare systems. In recent years (2015–2025), rapid advances in artificial intelligence (AI), particularly in deep learning and multimodal data integration, have significantly improved cardiovascular diagnostics. Aims: The aim of this study is to analyze current applications of AI in cardiology and to evaluate their impact on healthcare systems. Methods: This narrative review is based on recent scientific literature and focuses on electrocardiogram (ECG) analysis, cardiovascular imaging, and risk prediction models. Results: The findings indicate that AI improves diagnostic accuracy, reduces time to diagnosis, enhances clinical workflows, and supports healthcare efficiency. Furthermore, AI contributes to improved accessibility and better allocation of medical resources. However, challenges such as data bias, limited interpretability, ethical concerns, and regulatory barriers remain significant. Conclusion: AI has strong potential to transform healthcare systems but should be considered a complementary tool supporting clinical decision-making rather than replacing healthcare professionals.

  • Open Access

    EFFECTIVENESS OF COMPREHENSIVE LIFESTYLE INTERVENTIONS (DIET, EXERCISE, SLEEP, AND STRESS MODIFICATION) IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

    by Julia Czerniewska, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Dominika Dutkiewicz, Marta Handzel

    Background: Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder affecting women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction, insulin resistance, obesity, and psychological distress. Lifestyle modification is recommended as first-line therapy; however, the comparative effectiveness of multidomain interventions integrating diet, exercise, sleep optimization, and supplementation remains unclear. This systematic review and meta-analysis evaluated the impact of comprehensive lifestyle interventions on metabolic, hormonal, reproductive, inflammatory, and psychosocial outcomes in women with PCOS. Methods: A systematic literature search of PubMed/MEDLINE was conducted according to PRISMA 2020 guidelines. Randomized controlled trials published in English within the previous 10 years were included if they enrolled reproductive-aged women with confirmed PCOS and evaluated at least one lifestyle intervention: dietary modification, supplementation, structured exercise, sleep-related therapy, or combined programs. Outcomes included anthropometric indices, insulin resistance markers, lipid profile, reproductive and hormonal parameters, inflammatory biomarkers, sleep quality, and mental health. Where sufficient homogeneity existed, pooled quantitative analyses were planned; otherwise, narrative synthesis was performed. Results: Comprehensive lifestyle interventions demonstrated significant benefits across multiple domains. Dietary strategies, particularly calorie-restricted, low-glycemic-load, Mediterranean-style, and ketogenic diets, improved body weight, body mass index, waist circumference, insulin resistance, lipid profile, and androgen excess. Structured exercise, including aerobic training and high-intensity interval training, improved body composition, insulin sensitivity, menstrual cyclicity, ovarian morphology, cardiovascular fitness, and psychological well-being, while reducing inflammatory markers (CRP, IL-6, TNF-α). Adjunctive supplementation (probiotics, synbiotics, coenzyme Q10, omega-3 fatty acids, vitamin D, magnesium, flaxseed, and melatonin) showed additional improvements in metabolic, hormonal, oxidative stress, and menstrual outcomes. Sleep-focused interventions, particularly melatonin supplementation and behavioral modification, improved sleep quality, anxiety, depression, insulin resistance, and lipid parameters. Conclusions: Comprehensive lifestyle intervention is an effective evidence-based strategy for PCOS management. Combined approaches targeting nutrition, exercise, sleep, and selected supplementation improve metabolic, endocrine, reproductive, and psychological outcomes. Given the heterogeneity of PCOS, individualized multidisciplinary lifestyle treatment should be considered a central component of long-term care and may complement pharmacological therapy.

  • Open Access

    USE OF MOBILE HEALTH APPLICATIONS AND WEARABLE DEVICES IN PREVENTIVE HEALTH BEHAVIORS: A LITERATURE REVIEW

    by Mikołaj Dybicz, Olga Endler, Klaudia Jurkowska, Julia Mądrzak, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Dominika Dutkiewicz, Julia Czerniewska, Marta Handzel

    Background: Mobile health applications and wearable devices are increasingly recognized as tools that can support preventive health behaviors by enabling behavioral monitoring, real-time feedback, tailored recommendations and intervention delivery outside conventional in-person healthcare settings. Their preventive relevance is closely related to the fact that many major chronic diseases are strongly associated with modifiable risk factors, including physical inactivity, sedentary behavior, unhealthy diet, obesity, insufficient sleep and poor cardiometabolic control. Aim: The aim of this narrative review was to examine how mobile health applications and wearable devices are used to support preventive health behaviors, with particular attention to physical activity, sedentary behavior, diet, weight management, diabetes prevention, cardiovascular prevention, sleep, user engagement and behavior change mechanisms. Methods: This paper was prepared as a narrative literature review based exclusively on the available evidence base, including systematic reviews, meta-analyses, umbrella reviews, scoping reviews, narrative reviews and selected review-oriented empirical papers addressing mHealth, eHealth and wearable interventions. The findings were synthesized narratively and organized into major preventive domains, including physical activity, sedentary behavior, nutrition, obesity, type 2 diabetes risk, cardiovascular prevention, sleep, personalization, behavior change techniques and implementation barriers. Results: The literature suggests that mobile and wearable technologies most consistently improve physical activity, reduce sedentary behavior, support selected dietary improvements, assist weight control and improve sleep-related outcomes, whereas their effects on anthropometric, functional and some metabolic endpoints are often more modest or heterogeneous. The most promising interventions usually combine self-monitoring with feedback, goal setting, personalization, additional behavioral support and, in some cases, gamification or social features. At the same time, many reviews emphasize that effectiveness depends not only on the device or application itself, but also on intervention quality, sustained engagement, follow-up duration, data accuracy, usability, privacy, interoperability and equity of access. Conclusion: Mobile health applications and wearable devices represent valuable tools for supporting preventive health behaviors, but their role is strongest when they function as part of a broader, behaviorally informed intervention strategy rather than as stand-alone technological solutions. Current evidence supports their usefulness particularly in physical activity promotion, dietary behavior change, weight management and sleep support, while also highlighting the need for further research on long-term effectiveness, sustainability, personalization, data protection and equitable implementation.

  • Open Access

    OBESITY AND TYPE 2 DIABETES: THE ROLE OF LIFESTYLE, BIOLOGICAL MECHANISMS, AND SOCIO-TECHNOLOGICAL DETERMINANTS

    by Julia Mądrzak, Julia Czerniewska, Dominika Dutkiewicz, Jakub Fidelus, Magdalena Filuk, Marianna Ciastoń, Mikołaj Dybicz, Olga Endler, Klaudia Jurkowska, Marta Handzel

    Objective: The aim of this study is to provide a comprehensive overview of the relationship between obesity and type 2 diabetes (T2D) and to identify the key environmental, behavioral, and biological factors involved in their development. A review of current scientific literature concerning the epidemiology, pathophysiology, and risk factors of both conditions was conducted, with particular emphasis on the roles of diet, physical activity, gut microbiota, and socio-economic determinants. Analysis: The analysis demonstrated that obesity, particularly visceral adiposity, constitutes the primary risk factor for type 2 diabetes. The central mechanism linking these conditions is insulin resistance, which is exacerbated by chronic low-grade inflammation and adipose tissue dysfunction. Significant importance is attributed to unfavorable dietary patterns, including the high consumption of ultra-processed foods and high-glycemic-load diets, both of which promote metabolic disturbances. Furthermore, the role of gut microbiota in metabolic regulation was highlighted, alongside the impact of physical activity – specifically mechanisms involving GLUT4 translocation and Non-Exercise Activity Thermogenesis (NEAT) on improving glucose homeostasis. Additionally, environmental and socio-economic factors, such as urbanization, food accessibility, and educational attainment, significantly modulate disease risk. Conclusions: The findings indicate that obesity and type 2 diabetes share a common, multifactorial etiology. Consequently, effective prevention and management require an integrated approach encompassing lifestyle modifications, systemic interventions, and the utilization of modern health-supporting technologies.

  • Open Access

    LONG-TERM QUALITY OF LIFE AND PSYCHOSOCIAL DEVELOPMENT IN CHILDREN FOLLOWING CONGENITAL HEART DISEASE SURGERY – A NARRATIVE REVIEW

    by Klaudia Jurkowska, Julia Mądrzak, Dominika Dutkiewicz, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Magdalena Filuk, Jakub Fidelus, Julia Czerniewska, Marta Handzel

    Background: Advances in pediatric cardiac surgery have reduced congenital heart disease (CHD) mortality, shifting clinical focus toward optimizing long-term health-related quality of life (HRQoL). However, patients and caregivers still face significant psychosocial and neurodevelopmental challenges requiring holistic, technology-enhanced care. Aim: To synthesize current literature on the long-term psychosocial development of children following CHD surgery and evaluate the impact of technological interventions (e.g., telemedicine, e-Health) on mitigating these challenges for patients and families. Methods: This narrative review synthesizes evidence from recent systematic reviews, meta-analyses, and prospective cohort studies (emphasizing the 2021–2026 period) retrieved from PubMed, Scopus, and Web of Science. The review evaluates pediatric HRQoL, caregiver burden, and digital health interventions. Results: Despite physical improvements, CHD survivors face neurodevelopmental delays and peer marginalization. Parental stress profoundly impacts families; mothers of children with CHD exhibit significantly lower HRQoL in emotional role difficulty (SMD: -0.79) and general health (SMD: -0.58). Conversely, targeted interventions yield measurable benefits. Structured physical training in Fontan patients increases peak oxygen uptake by 1.72 ml/kg/min (6.3%). Furthermore, digital health solutions (mobile apps, wearables) significantly enhance patient engagement and disease management during the transition to adulthood. Conclusion: Enhancing the psychosocial well-being of CHD survivors and caregivers is crucial. Comprehensive postoperative care must evolve to integrate continuous psychological support, family-centered care, and modern technological solutions (e.g., interactive telehealth, advanced neuromonitoring) to ensure a satisfying quality of life.

  • Open Access

    SEX DIFFERENCES IN MELANOMA: HORMONAL, BIOLOGICAL, AND CLINICAL PERSPECTIVES – A LITERATURE REVIEW

    by Magdalena Filuk, Klaudia Jurkowska, Julia Mądrzak, Olga Endler, Mikołaj Dybicz, Marianna Ciastoń, Jakub Fidelus, Dominika Dutkiewicz, Julia Czerniewska, Marta Handzel

    Background: Melanoma is one of the most aggressive forms of skin cancer, with increasing global incidence and significant mortality. Despite advances in diagnosis and treatment, it remains a major public health concern. Consistent sex-related differences have been observed in melanoma epidemiology, clinical presentation, and survival outcomes. Aims: The aims of this review are to analyze sex-related differences in melanoma, focusing on epidemiology, biological mechanisms, clinical characteristics, and treatment outcomes, as well as their implications for public health and personalized medicine. Methods: A narrative literature review was conducted using PubMed and Google Scholar databases. Relevant studies published primarily within the last decade were included, with a focus on epidemiology, hormonal influences, immune system variability, tumor microenvironment, and treatment response in melanoma. Results: Women demonstrate a consistent survival advantage compared to men, partly explained by earlier diagnosis and more favorable tumor characteristics. However, biological factors, including hormonal influences and immune system differences, play a significant role in disease progression. Sex-related differences were also observed in treatment response, particularly in the context of immunotherapy, as well as in tumor biology and clinical presentation. Conclusion: Sex is an important factor influencing melanoma development, progression, and treatment outcomes. Understanding these differences may contribute to improved prevention strategies, earlier diagnosis, and more personalized therapeutic approaches. Incorporating sex-specific considerations into clinical practice and research may help reduce disparities in melanoma outcomes.